These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 30948912

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T, Shiraishi M, Ohta T, Sakai K, Ishii S.
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X, Chen S, Zhang L.
    Am J Physiol Endocrinol Metab; 2020 Jul 01; 319(1):E34-E42. PubMed ID: 32228319
    [Abstract] [Full Text] [Related]

  • 25. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells.
    Sharma A, Anand SK, Singh N, Dwivedi UN, Kakkar P.
    Eur J Pharmacol; 2020 Sep 05; 882():173244. PubMed ID: 32526241
    [Abstract] [Full Text] [Related]

  • 26. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
    Yu Q, Liu Y, Wu Y, Chen Y.
    Biomed Pharmacother; 2018 Jul 05; 103():1327-1336. PubMed ID: 29864915
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun H, Sun P, Yang X, Huo X, Peng J, Liu K.
    Phytomedicine; 2017 Feb 15; 25():83-92. PubMed ID: 28190475
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. BI-7273, a BRD9 inhibitor, reduces lipid accumulation by downregulating the AKT/mTOR/SREBP1 signaling pathway.
    Li Y, He Q, Chen S, Dli H, Zhao J, Sun X, Yang P, Mao Q, Xia H.
    Biochem Pharmacol; 2024 Aug 15; 226():116412. PubMed ID: 38971334
    [Abstract] [Full Text] [Related]

  • 38. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D, Cui H, Zhang Y.
    Cell Physiol Biochem; 2018 Aug 15; 45(6):2187-2198. PubMed ID: 29550812
    [Abstract] [Full Text] [Related]

  • 39. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT, Lu FH, Ou HY, Su YC, Hung HC, Wu JS, Yang YC, Wu CL, Chang CJ.
    J Hepatol; 2013 Nov 15; 59(5):1065-72. PubMed ID: 23792031
    [Abstract] [Full Text] [Related]

  • 40. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
    Xue W, Wang J, Jiang W, Shi C, Wang X, Huang Y, Hu C.
    Eur J Pharmacol; 2020 Mar 15; 871():172910. PubMed ID: 31926991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.